Deletion of PDE2, the gene encoding the high‐affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicans
Open Access
Abstract
A role for the cAMP‐dependent pathway in regulation of the cell wall in the model yeast Saccharomyces cerevisiae has recently been demonstrated. In this study we report the results of a phenotypic analysis of a Candida albicans mutant, characterized by a constitutive activation of the cAMP pathway due to deletion of PDE2, the gene encoding the high cAMP‐affinity phosphodiesterase. Unlike wild‐type strains, this mutant has an increased sensitivity to cell wall and membrane perturbing agents such as SDS and CFW, and antifungals such as amphotericin B and flucytosine. Moreover, the mutant is characterized by an altered sensitivity and a significantly reduced tolerance to fluconazole. The mutant's membrane has around 30% higher ergosterol content and the cell wall glucan was 22% lower than in the wild‐type. These cell wall and membrane changes are manifested by a considerable reduction in the thickness of the cell wall, which in the mutant is on average 60–65 nm, compared to 80–85 nm in the wild‐type strains as revealed by electron microscopy. These results suggest that constitutive activation of the cAMP pathway affects cell wall and membrane structure, and biosynthesis, not only in the model yeast S. cerevisiae but also in the human fungal pathogen C. albicans. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- Genome‐wide analysis of the effects of heat shock on a Saccharomyces cerevisiae mutant with a constitutively activated cAMP‐dependent pathwayComparative and Functional Genomics, 2004
- Transcriptome profiling of aSaccharomyces cerevisiaemutant with a constitutively activated Ras/cAMP pathwayPhysiological Genomics, 2003
- Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis InhibitorsAntimicrobial Agents and Chemotherapy, 2003
- Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular diseaseClinical Cardiology, 2002
- Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilutionClinical Microbiology and Infection, 2000
- Regulation of chitin synthesis during dimorphic growth of Candida albicansMicrobiology, 1998
- A Candida albicans cyclic nucleotide phosphodiesterase: cloning and expression in Saccharomyces cerevisiae and biochemical characterization of the recombinant enzymeMicrobiology, 1994
- The pde2 gene of Saccharomyces cerevisiae is allelic to rcal and encodes a phosphodiesterase which protects the cell from extracellullar cAMPFEBS Letters, 1993
- A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole‐sensitive and ‐resistant strainsJournal of Applied Bacteriology, 1990
- CandidaInfections: An OverviewCRC Critical Reviews in Microbiology, 1987